Hua Medicine

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Shanghai, CN
9 (est)+13%

Key People at Hua Medicine

Li Chen

Li Chen

President and CEO

Hua Medicine Locations

Shanghai, CN

Hua Medicine Metrics

Hua Medicine Summary

Hua Medicine News

Hua Medicine Company Life